References
- Herberman R B. Tumor immunology. JAMA 1992; 268: 2935–9
- Rosenberg S A. Immunotherapy of cancer using interleukin-2: current status and further prospects. Immunol Today 1988; 9: 58–62
- Kuby J. Immunology. Freeman WH and Company, New York 1992; 577–8
- Hellman S, Rosenberg S A. Important advances in oncology. Lippincott, Philadelphia 1986; 55–91
- Capelli E, Nano R, Cremaschi P, Lavezzi L, Rossi A, Cuccia M. Analysis of lymphocytes subsets sentitive to IL-2 stimulation in vitro. Med Biol Environment 1993; 21: 138–42
- Gerzeli G, De Piceis Polver P. Un nuovo metodo citochimico per lo studio dell'attività tetraidrofolico reduttasica in Plas-modium berghei: analisi dell'effetto di inhibitori specifici. Riv Parassitol 1969; 30: 19–26
- Li C Y, Yam L T, Lam K. W. Acid phosphatase isoenzyme in human lymphocytes in normal and pathologic conditions. J Histochem Cytochem 1970; 18: 473–81
- Higgy K E, Burns G F, Hayhoe F GJ. Discrimination of B, T and null lymphocytes by esterase cytochemistry. Scand J Haematol 1977; 18: 437–48
- Lorbacher P, Yam L T, Mitus W J. Cytochemical demonstration of β-glucuronidase activity in blood and bone marrow cells. J Histochem Cytochem 1967; 15: 680–7
- von Bertalanffy M, Masin M, Masin F. A new and rapid method for diagnosis of vaginal and cervical cancer by fluorescence microscopy. Cancer 1958; 11: 873–7
- Nano R, Capelli E, Cremaschi P, Catanese C, Gerzeli G. Morphofunctional characterization of human lymphokine activated killer (LAK) cells in vitro. Cell Molec Biol 1994, in press
- Arancia G, Sirianni M C, Malorni W. Suicide behavior of target cells after binding with natural killer cells. Blood Cells 1991; 17: 159–72